Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1891 AL 1905

Cerebrotendinous xanthomatosis presenting with asymmetric parkinsonism: a case with I-123-FP-CIT SPECT imaging

Schotsmans K, De Cauwer H, Baets J, Ceyssens S, van den Hauwe L, Deconinck T, Helsen G.

Acta Neurol Belg. 2012 Sep;112(3):287-9. doi: 10.1007/s13760-012-0064-7. Epub 2012 Apr 17.

SPECT molecular imaging in Parkinson's disease

Wang L, Zhang Q, Li H, Zhang H.

J Biomed Biotechnol. 2012;2012:412486. doi: 10.1155/2012/412486. Epub 2012 Mar 24.

Emerging analgesic drugs for Parkinson's disease

Perez-Lloret S, Rey MV, Dellapina E, Pellaprat J, Brefel-Courbon C, Rascol O.

Expert Opin Emerg Drugs. 2012 Jun;17(2):157-71. doi: 10.1517/14728214.2012.677949. Epub 2012 Apr 25.

The relationship between cerebral vascular disease and parkinsonism: The VADO study

Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP.

Parkinsonism Relat Disord. 2012 Jul;18(6):775-80. doi: 10.1016/j.parkreldis.2012.03.017. Epub 2012 Apr 22.

Impulse control disorders in Parkinson's disease: the role of personality and cognitive status

Poletti M, Bonuccelli U.

J Neurol. 2012 Nov;259(11):2269-77. doi: 10.1007/s00415-012-6506-6. Epub 2012 Apr 25.

LV dyssynchrony as assessed by phase analysis of gated SPECT myocardial perfusion imaging in patients with Wolff-Parkinson-White syndrome

Chen C, Li D, Miao C, Feng J, Zhou Y, Cao K, Lloyd MS, Chen J.

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1191-8. doi: 10.1007/s00259-012-2101-4. Epub 2012 Apr 25.

Cardiovascular variability in Parkinson's disease and extrapyramidal motor slowing

Brown R, Duma S, Piguet O, Broe GA, Macefield VG.

Clin Auton Res. 2012 Aug;22(4):191-6. doi: 10.1007/s10286-012-0163-9. Epub 2012 Apr 25.

Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis

Obeyesekere MN, Leong-Sit P, Massel D, Manlucu J, Modi S, Krahn AD, Skanes AC, Yee R, Gula LJ, Klein GJ.

Circulation. 2012 May 15;125(19):2308-15. doi: 10.1161/CIRCULATIONAHA.111.055350. Epub 2012 Apr 24.

Finasteride attenuates pathological gambling in patients with Parkinson disease

Bortolato M, Cannas A, Solla P, Bini V, Puligheddu M, Marrosu F.

J Clin Psychopharmacol. 2012 Jun;32(3):424-5. doi: 10.1097/JCP.0b013e3182549c2a.

New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism

Barbano RL, Hill DF, Snively BM, Light LS, Boggs N, McCall WV, Stacy M, Ozelius L, Sweadner KJ, Brashear A.

Parkinsonism Relat Disord. 2012 Jul;18(6):737-41. doi: 10.1016/j.parkreldis.2012.03.020. Epub 2012 Apr 24.

Recognition and diagnosis of sleep disorders in Parkinson's disease

Louter M, Aarden WC, Lion J, Bloem BR, Overeem S.

J Neurol. 2012 Oct;259(10):2031-40. doi: 10.1007/s00415-012-6505-7. Epub 2012 Apr 26.

Classic and new animal models of Parkinson's disease

Blesa J, Phani S, Jackson-Lewis V, Przedborski S.

J Biomed Biotechnol. 2012;2012:845618. doi: 10.1155/2012/845618. Epub 2012 Mar 28.

[(11)C]-[N-Methyl]3-[(3-fluorophenyl)sulfonyl]-8-(4-methyl-1-piperazinyl)quinoline

Chopra A.

2012 Feb 6 [updated 2012 Apr 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Safety considerations for patients with communication disorders in rehabilitation medicine settings

Cristian A, Giammarino C, Olds M, Adams E, Moriarty C, Ratner S, Mural S, Stobart EC.

Phys Med Rehabil Clin N Am. 2012 May;23(2):343-7. doi: 10.1016/j.pmr.2012.02.017. Epub 2012 Apr 10.

Modeling Parkinson's disease using induced pluripotent stem cells

Byers B, Lee HL, Reijo Pera R.

Curr Neurol Neurosci Rep. 2012 Jun;12(3):237-42. doi: 10.1007/s11910-012-0270-y.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias